tradingkey.logo

Inogen Inc

INGN
查看详细走势图
5.660USD
0.0000.00%
收盘 02/06, 16:00美东报价延迟15分钟
153.66M总市值
亏损市盈率 TTM

Inogen Inc

5.660
0.0000.00%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

-4.07%

1月

-22.68%

6月

-3.58%

今年开始到现在

-15.77%

1年

-46.65%

查看详细走势图

TradingKey Inogen Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Inogen Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名65/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价13.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Inogen Inc评分

相关信息

行业排名
65 / 205
全市场排名
175 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Inogen Inc亮点

亮点风险
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
估值合理
公司最新PE估值-5.65,处于3年历史合理位
机构减仓
最新机构持股19.79M股,环比减少18.29%
保罗·都铎·琼斯持仓
明星投资者保罗·都铎·琼斯持仓,最新持仓市值137.65K

分析师目标

根据 2 位分析师
买入
评级
13.000
目标均价
+122.60%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Inogen Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Inogen Inc简介

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
公司代码INGN
公司Inogen Inc
CEOSmith (Kevin R. M)
网址https://www.inogen.com/
KeyAI